Learning that a breast implant may be linked to a malignancy can be overwhelming. Breast implant-associated malignancies, including Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL), require prompt evaluation and carefully planned surgical treatment. Early intervention plays an important role in long-term outcomes and peace of mind.
Dr. Megan Fracol provides surgical care for implant-associated malignancies in Chicago, IL. An experienced plastic and reconstructive surgeon with training from MD Anderson Cancer Center, she helps patients understand their diagnoses and move forward with confidence and clarity.
What Are Breast Implant-Associated Malignancies?
Breast implant-associated malignancies are rare cancers that develop in the tissue surrounding a breast implant rather than in the breast itself. BIA-ALCL is the most well-known example and has been primarily associated with textured implants.
Common signs and symptoms may include:
-
Persistent swelling around the implant
-
Breast asymmetry or firmness
-
Fluid buildup years after implant placement
-
Discomfort or changes in breast shape
Evaluation often involves imaging, fluid analysis, and coordination with oncology specialists.
When Surgery Is Recommended
Surgery is the primary treatment for most implant-associated malignancies. The goal is to completely remove the implant and surrounding capsule to eliminate disease and reduce the risk of recurrence.
Surgical treatment may include:
-
Removal of the breast implant
-
Total capsulectomy (removal of the surrounding scar tissue)
-
Evaluation of nearby lymph nodes when indicated
Dr. Fracol tailors the surgical plan based on diagnosis, disease stage, and individual health factors.
Reconstruction After Implant Removal
Many patients wish to explore reconstruction following implant removal. Depending on medical recommendations, reconstruction options may include:
-
Autologous breast reconstruction using the patient’s own tissue
-
Delayed reconstruction after treatment completion
-
Flat closure for patients who prefer not to pursue reconstruction
Dr. Fracol discusses reconstruction timing and options once treatment planning is complete.
The Surgical Process
Procedures are performed in a hospital setting to allow comprehensive monitoring and coordination with medical teams. Surgery length and recovery depend on the extent of disease and whether reconstruction is performed at the same time.
Follow-up care focuses on healing, pathology review, and ongoing monitoring.
Recovery and Follow-Up Care
Recovery timelines vary, but most patients resume light activities within several weeks. Long-term follow-up is essential and may include:
-
Regular physical exams
-
Imaging when recommended
-
Collaboration with oncology providers
Clear communication and education remain central throughout recovery.
Why Choose Dr. Megan Fracol for Implant-Associated Malignancy Surgery in Chicago, IL?
Dr. Megan Fracol’s training includes advanced reconstructive and oncologic experience. She completed fellowship training in microsurgical reconstruction at MD Anderson Cancer Center and maintains hospital affiliations with Northwestern Memorial Hospital and Northwestern Lake Forest Hospital. Her academic background and research contributions – which include authoring over 30 publications and presenting her research at the American Association of Plastic Surgeons – allow her to approach implant-associated malignancies with careful planning and patient-centered care.
Move Forward After Diagnosis
Facing a diagnosis related to a breast implant can feel uncertain, but clear guidance and experienced surgical care can make the next steps more manageable. Dr. Megan Fracol provides thoughtful treatment planning and ongoing support in Chicago, IL. To discuss concerns related to breast implant-associated malignancies, contact her office at (312) 695-6022.